Due to the key role of TXNIP in regulating glucose metabolism for the suppression of cell survival, we determined TXNIP effect on BCR-ABL triggered glucose metabolic reprogramming in CML cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.